NRIX
Price
$18.86
Change
+$0.21 (+1.13%)
Updated
Jun 23 closing price
Capitalization
1.95B
15 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$1.80
Change
-$0.02 (-1.10%)
Updated
Jun 23 closing price
Capitalization
365.26M
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs PROK

NRIX vs PROK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRIX vs. PROK commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Buy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (NRIX: $18.86 vs. PROK: $1.78)
Brand notoriety: NRIX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 81% vs. PROK: 98%
Market capitalization -- NRIX: $1.95B vs. PROK: $365.26M
NRIX [@Biotechnology] is valued at $1.95B. PROK’s [@Biotechnology] market capitalization is $365.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 5 TA indicator(s) are bullish while PROK’s TA Score has 4 bullish TA indicator(s).

  • NRIX’s TA Score: 5 bullish, 5 bearish.
  • PROK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both NRIX and PROK are a good buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а +10.49% price change this week, while PROK (@Biotechnology) price change was +5.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.83%. For the same industry, the average monthly price growth was +1.96%, and the average quarterly price growth was +1945.11%.

Reported Earning Dates

NRIX is expected to report earnings on Jul 09, 2026.

PROK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+5.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.95B) has a higher market cap than PROK($365M). NRIX YTD gains are higher at: -0.580 vs. PROK (-20.536). PROK has higher annual earnings (EBITDA): -149.81M vs. NRIX (-296.79M). NRIX has more cash in the bank: 541M vs. PROK (225M). PROK has less debt than NRIX: PROK (3.78M) vs NRIX (58.7M). NRIX has higher revenues than PROK: NRIX (71.8M) vs PROK (889K).
NRIXPROKNRIX / PROK
Capitalization1.95B365M534%
EBITDA-296.79M-149.81M198%
Gain YTD-0.580-20.5363%
P/E RatioN/AN/A-
Revenue71.8M889K8,076%
Total Cash541M225M240%
Total Debt58.7M3.78M1,552%
FUNDAMENTALS RATINGS
NRIX: Fundamental Ratings
NRIX
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXPROK
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 19 days ago
86%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RAVI75.340.04
+0.05%
FlexShares Ultra-Short Income ETF
JLQD41.260.01
+0.02%
Janus Henderson Corporate Bond ETF
FTF5.76-0.02
-0.32%
Franklin Limited
DECZ42.67-0.21
-0.50%
TrueShares Structured Outcome Dec ETF
CBTA20.66-0.39
-1.88%
Calamos Bitcoin 80 Series Structured Alt Protection ETF - April

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+1.13%
KYMR - NRIX
55%
Loosely correlated
-1.22%
KURA - NRIX
50%
Loosely correlated
+0.19%
XNCR - NRIX
49%
Loosely correlated
+0.50%
IMVT - NRIX
47%
Loosely correlated
-1.26%
BCYC - NRIX
46%
Loosely correlated
+0.25%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-2.20%
RLYB - PROK
41%
Loosely correlated
-1.32%
SANA - PROK
39%
Loosely correlated
-0.30%
NRIX - PROK
39%
Loosely correlated
+1.13%
MAZE - PROK
38%
Loosely correlated
+3.29%
APGE - PROK
38%
Loosely correlated
+0.25%
More